IDEXX Laboratories, Inc. (IDXX)

Market Cap	37.07B
Revenue (ttm)	3.90B
Net Income (ttm)	887.87M
Shares Out	81.88M
EPS (ttm)	10.67
PE Ratio	42.43
Forward PE	37.84
Dividend	n/a
Ex-Dividend Date	n/a

Volume	688,510
Open	454.41
Previous Close	452.86
Day's Range	452.46 - 460.38
52-Week Range	398.50 - 583.39
Beta	1.37
Analysts	Buy
Price Target	533.75 (+17.89%)
Earnings Date	Feb 3, 2025

About IDXX

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnos...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Jun 21, 1991
• Employees: 11,000
• Stock Exchange: NASDAQ
• Ticker Symbol: IDXX
• Website: https://www.idexx.com

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Analyst Forecast

According to 8 analysts, the average rating for IDXX stock is "Buy." The 12-month stock price forecast is $533.75, which is an increase of 17.89% from the latest price.

Price Target

$533.75

(17.89% upside)

Analyst Consensus: Buy